VPIM
JAZZ icon

Vanguard Personalized Indexing Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.03M Sell
5,427
-54
-1% -$9.44K 0.01% 918
2025
Q4 		$932K Buy
5,481
+342
+7% +$52.4K 0.01% 953
2025
Q3 		$677K Buy
5,139
+1,134
+28% +$136K 0.01% 1099
2025
Q2 		$425K Sell
4,005
-4,919
-55% -$534K ﹤0.01% 1280
2025
Q1 		$1.11M Sell
8,924
-533
-6% -$69.5K 0.02% 732
2024
Q4 		$1.16M Buy
9,457
+4,054
+75% +$478K 0.02% 709
2024
Q3 		$602K Sell
5,403
-836
-13% -$91.6K 0.01% 1013
2024
Q2 		$664K Buy
6,239
+1,706
+38% +$188K 0.01% 887
2024
Q1 		$546K Sell
4,533
-3,068
-40% -$376K 0.01% 976
2023
Q4 		$935K Buy
7,601
+2,186
+40% +$273K 0.02% 687
2023
Q3 		$701K Buy
5,415
+1,260
+30% +$168K 0.02% 737
2023
Q2 		$515K Sell
4,155
-3,091
-43% -$416K 0.02% 879
2023
Q1 		$1.06M Buy
7,246
+3,349
+86% +$495K 0.04% 501
2022
Q4 		$621K Sell
3,897
-2,166
-36% -$317K 0.03% 718
2022
Q3 		$808K Sell
6,063
-849
-12% -$129K 0.04% 570
2022
Q2 		$1.08M Buy
6,912
+1,471
+27% +$226K 0.05% 429
2022
Q1 		$847K Buy
5,441
+3,819
+235% +$554K 0.04% 546
2021
Q4 		$207K Buy
+1,622
New +$213K 0.01% 986
2021
Q3 		– Sell
-2,052
Closed -$365K – 1018
2021
Q2 		$365K Buy
+2,052
New +$355K 0.04% 647

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Personalized Indexing Management's JAZZ Position: Q1 2026 in Review

Vanguard Personalized Indexing Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.99% in Q1 2026, selling an estimated $9.44K and leaving 5,427 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #918.

Vanguard Personalized Indexing Management first reported a position in JAZZ in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.16M in Q4 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Vanguard Personalized Indexing Management held 5,427 shares of Jazz Pharmaceuticals worth $1.03M as of Q1 2026.
  • Vanguard Personalized Indexing Management sold 54 Jazz Pharmaceuticals shares in Q1 2026, an estimated $9.44K.
  • Jazz Pharmaceuticals made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #918 holding.
  • Vanguard Personalized Indexing Management first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 19 quarters since.
  • Vanguard Personalized Indexing Management's Jazz Pharmaceuticals position peaked at $1.16M in Q4 2024.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.